ArticleBMC cancer2024

The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy.

Lin-Feng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.